BC
HALO icon

Bridgefront Capital’s Halozyme HALO Stock Holding History

Bridgefront Capital’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$307K Buy
+3,921
New +$267K 0.08% 375
2025
Q4 		– Sell
-6,815
Closed -$500K – 631
2025
Q3 		$500K Buy
6,815
+295
+5% +$19.6K 0.15% 249
2025
Q2 		$339K Buy
+6,520
New +$371K 0.09% 393
2023
Q4 		– Sell
-6,238
Closed -$238K – 446
2023
Q3 		$238K Buy
+6,238
New +$256K 0.17% 274
2021
Q3 		– Sell
-9,230
Closed -$419K – 481
2021
Q2 		$419K Buy
9,230
+4,142
+81% +$183K 0.16% 230
2021
Q1 		$212K Sell
5,088
-6,916
-58% -$316K 0.07% 561
2020
Q4 		$513K Buy
+12,004
New +$431K 0.18% 201

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Bridgefront Capital's HALO Position: Q2 2026 in Review

Bridgefront Capital opened a new position in Halozyme (HALO) in Q2 2026: 3,921 shares worth $307K. The stake represents 0.08% of the portfolio and ranks #375 among its holdings. This is a return to the name: Bridgefront Capital previously reported a position in HALO as recently as Q3 2025.

Bridgefront Capital first reported a position in HALO in Q4 2020 and has held it in 7 quarters since. The position peaked at $513K in Q4 2020. 674 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Bridgefront Capital held 3,921 shares of Halozyme worth $307K as of Q2 2026.
  • Halozyme was a new Bridgefront Capital position in Q2 2026.
  • Halozyme made up 0.08% of Bridgefront Capital's portfolio in Q2 2026, its #375 holding.
  • Bridgefront Capital first reported a position in Halozyme in Q4 2020 and has held it in 7 quarters since.
  • Bridgefront Capital's Halozyme position peaked at $513K in Q4 2020.
  • 674 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.